These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38504555)

  • 1. Remimazolam for sedation and anesthesia in children: Protocol for a scoping review.
    Brüggemann V; Hansen TG
    Acta Anaesthesiol Scand; 2024 Jul; 68(6):848-851. PubMed ID: 38504555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remimazolam for sedation and anesthesia in children: A scoping review.
    Kuklin V; Hansen TG
    Acta Anaesthesiol Scand; 2024 Aug; 68(7):862-870. PubMed ID: 38722151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical role of remimazolam: Protocol for a scoping review.
    Intzilaki CV; Davodi J; Vilmann P; Møller AM
    Acta Anaesthesiol Scand; 2024 Aug; 68(7):956-959. PubMed ID: 38561232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics.
    Antonik LJ; Goldwater DR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):274-83. PubMed ID: 22190555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
    Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-to-Event Modeling for Remimazolam for the Indication of Induction and Maintenance of General Anesthesia.
    Lohmer LL; Schippers F; Petersen KU; Stoehr T; Schmith VD
    J Clin Pharmacol; 2020 Apr; 60(4):505-514. PubMed ID: 31989598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Application and Research Progress of Remimazolam for Pediatric Patients.
    Bai C; Xu M; Guo Y; Jin Y; Zhao X
    Drug Des Devel Ther; 2024; 18():1221-1229. PubMed ID: 38645987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remimazolam - current knowledge on a new intravenous benzodiazepine anesthetic agent.
    Kim SH; Fechner J
    Korean J Anesthesiol; 2022 Aug; 75(4):307-315. PubMed ID: 35585830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remimazolam: Pharmacologic Considerations and Clinical Role in Anesthesiology.
    Wesolowski AM; Zaccagnino MP; Malapero RJ; Kaye AD; Urman RD
    Pharmacotherapy; 2016 Sep; 36(9):1021-7. PubMed ID: 27496519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A miniature pig model of pharmacological tolerance to long-term sedation with the intravenous benzodiazepines; midazolam and remimazolam.
    Io T; Saunders R; Pesic M; Petersen KU; Stoehr T
    Eur J Pharmacol; 2021 Apr; 896():173886. PubMed ID: 33493482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of concurrent remifentanil on the sedative effects of remimazolam, midazolam and propofol in cynomolgus monkeys.
    Kops MS; Pesic M; Petersen KU; Schmalix WA; Stöhr T
    Eur J Pharmacol; 2021 Jan; 890():173639. PubMed ID: 33065095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety, pharmacokinetic and pharmacodynamic properties of single ascending dose and continuous infusion of remimazolam besylate in healthy Chinese volunteers.
    Sheng XY; Liang Y; Yang XY; Li LE; Ye X; Zhao X; Cui YM
    Eur J Clin Pharmacol; 2020 Mar; 76(3):383-391. PubMed ID: 31873765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase IIb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopy.
    Pambianco DJ; Borkett KM; Riff DS; Winkle PJ; Schwartz HI; Melson TI; Wilhelm-Ogunbiyi K
    Gastrointest Endosc; 2016 May; 83(5):984-92. PubMed ID: 26363333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and Pharmacodynamics of Remimazolam (CNS 7056) after Continuous Infusion in Healthy Male Volunteers: Part I. Pharmacokinetics and Clinical Pharmacodynamics.
    Schüttler J; Eisenried A; Lerch M; Fechner J; Jeleazcov C; Ihmsen H
    Anesthesiology; 2020 Apr; 132(4):636-651. PubMed ID: 31972655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remimazolam: A Review in Procedural Sedation.
    Lee A; Shirley M
    Drugs; 2021 Jul; 81(10):1193-1201. PubMed ID: 34196946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of remimazolam in procedural sedation and analgesia: A protocol for systematic review and meta analysis.
    Wang F; Zhou Q; Shen M; Quan J; Chen J; Shi J; Zou X
    Medicine (Baltimore); 2020 Jul; 99(27):e20765. PubMed ID: 32629656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remimazolam for sedation: A protocol for a systematic review with meta-analysis, trial sequential analysis, and GRADE approach.
    Stehr-Pingel L; Maagaard M; Tvarnø CD; Andersen LPK; Andersen JH; Mathiesen O
    Acta Anaesthesiol Scand; 2023 Nov; 67(10):1432-1438. PubMed ID: 37580880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remimazolam Has Low Oral Bioavailability and No Potential for Misuse in Drug-Facilitated Sexual Assaults, with or Without Alcohol: Results from Two Randomised Clinical Trials.
    Pesic M; Stöhr T; Ossig J; Borkett K; Donsbach M; Dao VA; Webster L; Schippers F
    Drugs R D; 2020 Sep; 20(3):267-277. PubMed ID: 32757149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sedation outcomes for remimazolam, a new benzodiazepine.
    Oka S; Satomi H; Sekino R; Taguchi K; Kajiwara M; Oi Y; Kobayashi R
    J Oral Sci; 2021 Jun; 63(3):209-211. PubMed ID: 34092775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.